Tudor–Eliade Ciuleanu
Iuliu Hațieganu University of Medicine and Pharmacy(RO)Institute of Oncology Prof. Dr. Ion Chiricuta(RO)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Erlotinib in Previously Treated Non–Small-Cell Lung Cancer(2005)5,440 cited
- → Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden(2018)3,112 cited
- → First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer(2017)2,557 cited
- → Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)(2005)2,088 cited
- → Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial(2014)1,480 cited
- → First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial